危重症患者临床试验中替代决策者提供同意的障碍与促进因素:一项定性研究
该研究通过对20名接受机械通气的危重症患者的替代决策者进行半结构化访谈,探讨重症临床试验入组的障碍与促进因素。主题分析确认了信任、风险获益评估、利他及知识生成等既往已知因素,并新发现对干扰临床治疗决策的担忧及对安慰剂的负面情绪。替代决策者正面看待公开表彰和慈善捐款,但对直接经济激励和优先研究参与者持负面态度。
要点
- 信任医疗系统与利他动机是替代决策者同意入组的主要促进因素。
- 对干扰临床治疗决策的担忧及对安慰剂的负面情绪是新发现的障碍。
- 公开表彰与慈善捐款被视为促进入组的有利措施,而直接经济激励不受欢迎。
核心结论
- 卫生系统信任、研究风险获益、利他主义、知识生成、对临床照护的干扰及安慰剂是替代决策者同意危重症试验入组的关键顾虑与障碍。
- 未来需评估以患者名义慈善捐款及公开表彰是否有效促进危重症试验入组。
研究设计与样本
- 对20名接受机械通气的危重症患者的替代决策者进行半结构化访谈。
- 访谈录音并逐字转录,采用归纳法进行主题分析。
主要发现
- 主题分析确认信任系统、评估试验风险获益、帮助他人愿望及构建医学知识是入组的重要促进因素。
- 识别出两个既往未描述的顾虑:可能干扰临床治疗决策及对安慰剂的负面情绪。
- 替代决策者正面看待公开表彰和慈善捐款,负面看待直接经济激励及在查房时优先研究参与者。
临床怎么用
- 与替代决策者沟通时需关注其对临床治疗决策干扰及安慰剂的顾虑。
- 可考虑采用公开表彰或慈善捐款等非经济激励策略促进试验入组。
- 避免使用直接经济激励或在医疗查房中优先研究参与者的做法。
局限性
- 样本量较小(20名替代决策者),可能限制结果的普遍性。
- 定性研究设计无法评估所提议干预措施的实际效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enrollment into critical care clinical trials is often hampered by the need to rely on surrogate decision-makers. To identify potential interventions facilitating enrollment into critical care clinical trials, a better understanding of surrogate decision-making for critical care clinical trial enrollment is needed. RESEARCH QUESTION: What are the barriers and facilitators of critical care trial enrollment? What are surrogate decision-makers' perspectives on proposed interventions to facilitate trial enrollment? STUDY DESIGN AND METHODS: We conducted semistructured interviews with 20 surrogate decision-makers of critically ill patients receiving mechanical ventilation. The interviews were recorded and transcribed verbatim, and analyzed for themes using an inductive approach. RESULTS: Thematic analysis confirmed previous research showing that trust in the system, assessing the risks and benefits of trial participation, the desire to help others, and building medical knowledge as important motivating factors for trial enrollment. Two previously undescribed concerns among surrogate decision-makers of critically ill patients were identified, including the potential to interfere with clinical treatment decisions and negative sentiment about placebos. Surrogates viewed public recognition and charitable donations for participation as favorable potential interventions to encourage trial enrollment. However, participants viewed direct financial incentives and prioritizing research participants during medical rounds negatively. INTERPRETATION: This study confirms and extends previous findings that health system trust, study risks and benefits, altruism, knowledge generation, interference with clinical care, and placebos are key concerns and barriers for surrogate decision-makers to enroll patients in critical care trials. Future studies are needed to evaluate if charitable giving on the patient's behalf and public recognition are effective strategies to promote enrollment into critical care trials.
引用
- Krutsinger DC, Maloney SI, Courtright KR, et al. Barriers and Facilitators of Surrogates Providing Consent for Critically Ill Patients in Clinical Trials: A Qualitative Study. Chest. 2024. PMID: 38387647. doi:10.1016/j.chest.2024.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。